Page 41 - Orvosoktatás - Aki a szívizom incfartust túlélte
P. 41

41






            Irodalom


            1. Braunwald E. The path to an angiotensin receptor  of the effect of coenzyme Q on congestive heart
            antagonistneprilysin inhibitor in the treatment of heart  failure. Jap Heart J 1976; 17: 32–42.
            failure. J Am Coll Cardiol 2015; 65: 1029–1041.   8. Folkers K, Vadhanavikit S, Mortensen SA. Biochemical
            2. ESC Guideline. Az akut és krónikus szívelégtelen-  rationate and myocardial tissue data ont he effective
            ség diagnózisa és kezelése – 2012. Card Hung 2012;  therapy of cardiomyopathy with coenzym Q . Proc
                                                                                                      10
            suppl. F.                                         Natl Acad Sci USA 1985; 82: 901–904.
            3. Hess OM, McKenna W, Schultheiss H-P, et  9. Fotino AD, Thompson-Paul AM, Bazzano LA. Effect
            al. Myocardial disease. In: The ESC Textbook of  of coenzym Q  supplementation on heart failure:
                                                                           10
            Cardiovascular Medicine (editors: AJ. Camm, Tu. F.  a meta-analysis. Am J Clin Nutr 2013; 97: 268–275.
            Lüscher, PW. Serruys), Blackwell Publ. Oxford. Pp.  10.  Molyneux  SL,  Florkowski  CM,  George  PM,  et
            453–515.                                          al. Coenzyme Q – an independent prediktor of
                                                                              10
            4. ESC Guideline. The diagnosis and management of  mortality in chronic heart failure. J Am Coll Cardiol
            hypertrophic cardiomyopathy. Eur Heart J 2014-doi  2008; 52: 1435–41.
            10.10.109/eurheart/ ehu284.                       11. Alchagon V, Johansson P, Björnstedt M, et al.
            5. Mortensen SA, Rosenfeldt F, Kumar A, et al. The  Cardiovascular mortality and N-terminal-pro BNP
            effect of coenzyme Q  on morbidity and mortality  reduced after combined selenium and coenzyme Q
                                 10                                                                        10
            in chronic heart failure. J Am Coll Cardiol HF 2014;  supplementation. A 5-year prospective randomized
            2 (6): 641-49.                                    double-blind placebo-controlled trial among elderly
            6. Gao D, Ning N, Niu X, et al. Trimetazidine: a meta-  Swedish citizens. Int J Cardiol 2013; 167: 1860–66.
            analysis  of randomized  controlled  trials in  heart  12. Borbola J. A cardiomyopathiák fajtái, a megelő-
            failure. Heart 2011; 97: 278–286.                 zés és a kezelés új lehetőségei. Card Hung 2016; 46:
            7. Ishiyama T, Morita Y, Toyama S, et al. A clinical study  B2–B5.
   36   37   38   39   40   41   42   43   44   45   46